Back
Pliant Therapeutics Vs. Avalo Therapeutics Industry Stock Comparison
Buy
52
PLRX
Pliant Therapeutics
Last Price:
13.96
Seasonality Move:
39.12%
Sell
32
AVTX
Avalo Therapeutics
Last Price:
14.01
Seasonality Move:
-8.31%
Buy
52
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy, Sell or Hold?
- The current Pliant Therapeutics [PLRX] share price is $13.98. The Score for PLRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- PLRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy, Sell or Hold?
- The current Avalo Therapeutics [AVTX] share price is $14.36. The Score for AVTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- AVTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $13.98
The current trend is relatively stagnant and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVTX Stock Price Chart
What is Avalo Therapeutics's stock price today?
-
The Avalo Therapeutics share price today is $14.36
The current trend is moderately bearish and AVTX is experiencing slight selling pressure.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 56.16 | Buy |
| Chaikin Money Flow: | 172121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.28 - 14.48) | Buy |
| Bollinger Bands (100): | (13.91 - 17.65) | Sell |
AVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.31 | Buy |
| Relative Strength Index (14 RSI): | 53.02 | Buy |
| Chaikin Money Flow: | -13822 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.43 - 16.57) | Sell |
| Bollinger Bands (100): | (3.91 - 13.49) | Buy |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.42 | Buy |
| 20-day SMA: | 13.06 | Buy |
| 50-day SMA: | 14.41 | Sell |
| 200-day SMA: | 15.86 | Sell |
| 8-day EMA: | 12.84 | Buy |
| 20-day EMA: | 13.09 | Buy |
| 50-day EMA: | 14.11 | Sell |
| 200-day EMA: | 16.34 | Sell |
AVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.61 | Sell |
| 20-day SMA: | 14.65 | Sell |
| 50-day SMA: | 10.23 | Buy |
| 200-day SMA: | 19.71 | Sell |
| 8-day EMA: | 15.22 | Sell |
| 20-day EMA: | 14.28 | Buy |
| 50-day EMA: | 12.05 | Buy |
| 200-day EMA: | 135.87 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.
Avalo Therapeutics Earnings Growth & AVTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.
Pliant Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avalo Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||